menstrual - Anormalities

Reading File
Finding Sources
Finding Sources
Searching Images

menstrual cycle abnormalities diagram

A multi-panel pathophysiology diagram illustrating the synchronous physiological changes during a standard 28-day human menstrual cycle. The top panel graphs gonadotropin levels, showing a sharp surge in Luteinizing Hormone (LH) and a moderate rise in Follicle-Stimulating Hormone (FSH) at day 14, correlating with the follicular phase, ovulation, and luteal phase stages. The corresponding follicular development shows the maturation of a primary follicle into a Graafian follicle, ovulation, and the formation of the corpus luteum and corpus albicans. The middle panel tracks plasma sex hormone levels, highlighting the mid-cycle peak of Estradiol (E2) and the post-ovulatory rise of Progesterone (P4). The bottom panel depicts endometrial morphology, transitioning from the menstrual phase to the proliferative and secretory phases. A green-shaded layer highlights the glycocalyx development, which thickens and becomes most prominent during the secretory phase under the influence of P4, before thinning during menstruation. The diagram demonstrates the hormonal regulation of the ovary and uterine lining for medical educational purposes.

A multi-panel pathophysiology diagram illustrating the synchronous physiological changes during a standard 28-day human menstrual cycle. The top panel graphs gonadotropin levels, showing a sharp surge in Luteinizing Hormone (LH) and a moderate rise in Follicle-Stimulating Hormone (FSH) at day 14, correlating with the follicular phase, ovulation, and luteal phase stages. The corresponding follicular development shows the maturation of a primary follicle into a Graafian follicle, ovulation, and the formation of the corpus luteum and corpus albicans. The middle panel tracks plasma sex hormone levels, highlighting the mid-cycle peak of Estradiol (E2) and the post-ovulatory rise of Progesterone (P4). The bottom panel depicts endometrial morphology, transitioning from the menstrual phase to the proliferative and secretory phases. A green-shaded layer highlights the glycocalyx development, which thickens and becomes most prominent during the secretory phase under the influence of P4, before thinning during menstruation. The diagram demonstrates the hormonal regulation of the ovary and uterine lining for medical educational purposes.

A multi-panel neuroimaging diagram illustrating effective connectivity differences across the menstrual cycle within a triple-network model. The networks include the Default Mode Network (DMN), Salience Network (SN), and Executive Control Network (ECN). The panels (a-f) represent directed connectivity between networks: DMN to SN, SN to DMN, DMN to ECN, ECN to DMN, SN to ECN, and ECN to SN. Results are categorized into three cycle phase comparisons: Pre-ovulatory vs. Early Follicular, Luteal vs. Early Follicular, and Luteal vs. Pre-ovulatory. Brain regions are depicted as colored nodes (e.g., mPFC, PCC, ACC, AI, MFG, SMG) on axial schematic brain templates. Arrows indicate the direction and strength (width) of connectivity differences. Black arrows represent positive differential connectivity, while red arrows represent negative differential connectivity. Asterisks denote connections with high statistical significance (posterior probability >95%). This resource facilitates understanding of how endogenous hormonal fluctuations modulate functional brain architecture and inter-network communication in healthy adult females.

A multi-panel neuroimaging diagram illustrating effective connectivity differences across the menstrual cycle within a triple-network model. The networks include the Default Mode Network (DMN), Salience Network (SN), and Executive Control Network (ECN). The panels (a-f) represent directed connectivity between networks: DMN to SN, SN to DMN, DMN to ECN, ECN to DMN, SN to ECN, and ECN to SN. Results are categorized into three cycle phase comparisons: Pre-ovulatory vs. Early Follicular, Luteal vs. Early Follicular, and Luteal vs. Pre-ovulatory. Brain regions are depicted as colored nodes (e.g., mPFC, PCC, ACC, AI, MFG, SMG) on axial schematic brain templates. Arrows indicate the direction and strength (width) of connectivity differences. Black arrows represent positive differential connectivity, while red arrows represent negative differential connectivity. Asterisks denote connections with high statistical significance (posterior probability >95%). This resource facilitates understanding of how endogenous hormonal fluctuations modulate functional brain architecture and inter-network communication in healthy adult females.

This pathophysiology diagram illustrates hallmarks of major depressive disorder (MDD) across various stages of the female reproductive lifespan, including reproductive age, pregnancy, and peri- and postmenopause. A line graph labeled 'Physiological Hormonal Fluctuations' depicts the 28-day menstrual cycle, showing estrogen peaks prior to ovulation (Day 14) and progesterone dominance during the luteal phase. A signaling pathway shows how progesterone fluctuations lead to GABA and serotonin receptor modulation, contributing to premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD). In the pregnancy/postpartum pathway, reduced allopregnanolone levels and GABA alterations are linked to postpartum depression (PPD). The peri- and postmenopausal section illustrates declining estradiol (E2) and progesterone, linked to the intensification of depressive symptoms. The diagram also highlights secondary factors, including impaired estrobolome function (gut-microbiome-estrogen axis) involving bacteria like Prevotella and Ruminococcus, and an immune component characterized by attenuated microglia and inflammatory responses compared to men. This visualization integrates endocrinology, neurobiology, and immunology to explain sex-specific vulnerabilities in mood disorders.

This pathophysiology diagram illustrates hallmarks of major depressive disorder (MDD) across various stages of the female reproductive lifespan, including reproductive age, pregnancy, and peri- and postmenopause. A line graph labeled 'Physiological Hormonal Fluctuations' depicts the 28-day menstrual cycle, showing estrogen peaks prior to ovulation (Day 14) and progesterone dominance during the luteal phase. A signaling pathway shows how progesterone fluctuations lead to GABA and serotonin receptor modulation, contributing to premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD). In the pregnancy/postpartum pathway, reduced allopregnanolone levels and GABA alterations are linked to postpartum depression (PPD). The peri- and postmenopausal section illustrates declining estradiol (E2) and progesterone, linked to the intensification of depressive symptoms. The diagram also highlights secondary factors, including impaired estrobolome function (gut-microbiome-estrogen axis) involving bacteria like Prevotella and Ruminococcus, and an immune component characterized by attenuated microglia and inflammatory responses compared to men. This visualization integrates endocrinology, neurobiology, and immunology to explain sex-specific vulnerabilities in mood disorders.

This composite educational graphic illustrates the morphological and hormonal changes of the human endometrium across a standard 28-day uterine cycle. The top section features a pathophysiology diagram showing fluctuations in estradiol (E2) and progesterone (P). E2 peaks during the proliferative phase, correlating with endometrial growth, while P dominates the secretory phase, driving glandular coiling and the 'window of implantation' (WOI). Below the hormone curves, a cross-sectional illustration depicts the histological evolution of endometrial glands and spiral arteries. It transitions from a thin, shedding layer in the menstrual phase to elongated glands during the proliferative phase, and finally to highly coiled, secretory glands with increased angiogenesis in the secretory phase. The bottom section displays three diagnostic ultrasound images of the uterus, providing clinical correlation of endometrial thickness: 2 mm (early proliferative), 11 mm (late proliferative), and 14 mm (mid-secretory). Key physiological processes such as post-menstrual repair, cellular proliferation, angiogenesis, and stromal decidualization are annotated to link hormonal signaling with macroscopic and microscopic changes.

This composite educational graphic illustrates the morphological and hormonal changes of the human endometrium across a standard 28-day uterine cycle. The top section features a pathophysiology diagram showing fluctuations in estradiol (E2) and progesterone (P). E2 peaks during the proliferative phase, correlating with endometrial growth, while P dominates the secretory phase, driving glandular coiling and the 'window of implantation' (WOI). Below the hormone curves, a cross-sectional illustration depicts the histological evolution of endometrial glands and spiral arteries. It transitions from a thin, shedding layer in the menstrual phase to elongated glands during the proliferative phase, and finally to highly coiled, secretory glands with increased angiogenesis in the secretory phase. The bottom section displays three diagnostic ultrasound images of the uterus, providing clinical correlation of endometrial thickness: 2 mm (early proliferative), 11 mm (late proliferative), and 14 mm (mid-secretory). Key physiological processes such as post-menstrual repair, cellular proliferation, angiogenesis, and stromal decidualization are annotated to link hormonal signaling with macroscopic and microscopic changes.

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Searching Images

amenorrhea causes classification flowchart

Summary : This flowchart outlines the classification and causes of comitant strabismus, dividing cases based on the presence or absence of diplopia, and further categorizing by horizontal or vertical deviation and specific etiologies.

flowchart:
# Nodes :
  • Comitant (root node, rectangle)
  • Diplopia (rectangle)
    • Horizontal (rectangle)
      • ET (rectangle)
        • Decompensated E (rectangle)
          • Age-related (rectangle)
          • Divergence insuff (rectangle)
          • TED (rectangle)
          • Sagging eye (rectangle)
          • Fixation switch (rectangle)
          • Post retinal surgery (rectangle)
      • XT (rectangle)
        • Decompensated X (rectangle)
        • CI (rectangle)
        • MG (rectangle)
        • TED (rectangle)
    • Vertical (rectangle)
      • Decompensated H (rectangle)
      • Skew (rectangle)
      • MG (rectangle)
      • TED (rectangle)
  • No diplopia (rectangle)
    • Sensory (rectangle)
      • Recurrent childhood strabismus (rectangle)

# Connectors :
  • Comitant splits into Diplopia and No diplopia.
  • Diplopia splits into Horizontal and Vertical.
  • Horizontal splits into ET and XT.
  • ET leads to Decompensated E, which branches into Age-related, Divergence insuff, TED, Sagging eye, Fixation switch, and Post retinal surgery.
  • XT leads to Decompensated X, CI, MG, and TED.
  • Vertical leads to Decompensated H, Skew, MG, and TED.
  • No diplopia leads to Sensory, which leads to Recurrent childhood strabismus.

# Layout :
  • Hierarchical, top-down tree structure.
  • Main branches: Diplopia (left, subdivided into Horizontal and Vertical) and No diplopia (right, subdivided into Sensory).

# Analysis :
  • The flowchart systematically categorizes comitant strabismus based on diplopia presence, then by deviation direction (horizontal/vertical), and finally by specific etiologies.
  • Multiple causes are listed for each subtype, highlighting the complexity and variety of underlying mechanisms.
  • TED (Thyroid Eye Disease) and MG (Myasthenia Gravis) appear as causes in both horizontal and vertical diplopia, indicating their broad impact.
  • The "No diplopia" branch is much simpler, focusing on sensory causes and recurrent childhood strabismus.

Summary : This flowchart outlines the classification and causes of comitant strabismus, dividing cases based on the presence or absence of diplopia, and further categorizing by horizontal or vertical deviation and specific etiologies. flowchart: # Nodes : • Comitant (root node, rectangle) • Diplopia (rectangle) • Horizontal (rectangle) • ET (rectangle) • Decompensated E (rectangle) • Age-related (rectangle) • Divergence insuff (rectangle) • TED (rectangle) • Sagging eye (rectangle) • Fixation switch (rectangle) • Post retinal surgery (rectangle) • XT (rectangle) • Decompensated X (rectangle) • CI (rectangle) • MG (rectangle) • TED (rectangle) • Vertical (rectangle) • Decompensated H (rectangle) • Skew (rectangle) • MG (rectangle) • TED (rectangle) • No diplopia (rectangle) • Sensory (rectangle) • Recurrent childhood strabismus (rectangle) # Connectors : • Comitant splits into Diplopia and No diplopia. • Diplopia splits into Horizontal and Vertical. • Horizontal splits into ET and XT. • ET leads to Decompensated E, which branches into Age-related, Divergence insuff, TED, Sagging eye, Fixation switch, and Post retinal surgery. • XT leads to Decompensated X, CI, MG, and TED. • Vertical leads to Decompensated H, Skew, MG, and TED. • No diplopia leads to Sensory, which leads to Recurrent childhood strabismus. # Layout : • Hierarchical, top-down tree structure. • Main branches: Diplopia (left, subdivided into Horizontal and Vertical) and No diplopia (right, subdivided into Sensory). # Analysis : • The flowchart systematically categorizes comitant strabismus based on diplopia presence, then by deviation direction (horizontal/vertical), and finally by specific etiologies. • Multiple causes are listed for each subtype, highlighting the complexity and variety of underlying mechanisms. • TED (Thyroid Eye Disease) and MG (Myasthenia Gravis) appear as causes in both horizontal and vertical diplopia, indicating their broad impact. • The "No diplopia" branch is much simpler, focusing on sensory causes and recurrent childhood strabismus.

Summary : This flowchart presents the updated nomenclature and classification of Steatotic Liver Disease (SLD), breaking it down into four main categories based on underlying causes and risk factors, including metabolic dysfunction, alcohol intake, and other etiologies.

flowchart:
# Nodes :
  • Steatotic Liver Disease (SLD) (main category, leftmost node with icon)
  • MASLD (Metabolic dysfunction–associated steatotic liver disease) (blue rectangle)
    – Steatosis with ≥1 cardiometabolic risk factors:
      • Prediabetes or diabetes
      • Overweight or obesity
      • Dyslipidemia (or on lipid-lowering therapy)
      • Hypertension (or on BP-lowering medication)
  • MetALD (MASLD with increased alcohol intake) (dark red rectangle)
    – MASLD in the setting of increased alcohol consumption (between 20 and 50 g/day in women and 30 and 60 g/day in men)
  • ALD (Alcohol-associated liver disease) (orange rectangle)
    – Steatosis in the setting of sustained increased alcohol consumption (>50 g/day in women and >60 g/day in men)
  • Other Causes of SLD (gray rectangle)
    – Known causes: drug-induced steatosis, monogenic SLD, and others
    – Cryptogenic: unknown
    – Steatosis without cardiometabolic risk factors or without excessive alcohol use (future MASLD?)

# Connectors :
  • SLD branches rightward into four categories: MASLD, MetALD, ALD, and Other Causes of SLD.
  • Each category is connected with a rightward arrow from SLD.
  • MetALD and ALD are sequentially related by alcohol intake thresholds.

# Layout :
  • Vertical stack of four colored rectangles (MASLD, MetALD, ALD, Other Causes of SLD) to the right of the main SLD node.
  • Arrows point from the main SLD node to each category.
  • Explanatory bullet points within each rectangle.

# Analysis :
  • The flowchart clarifies the new classification of SLD, distinguishing between metabolic and alcohol-related causes.
  • MASLD is defined by the presence of metabolic risk factors, while MetALD and ALD are differentiated by levels of alcohol intake.
  • "Other Causes" captures less common or unknown etiologies.
  • The structure emphasizes the importance of both metabolic and alcohol-related factors in the diagnosis and categorization of steatotic liver disease.

Summary : This flowchart presents the updated nomenclature and classification of Steatotic Liver Disease (SLD), breaking it down into four main categories based on underlying causes and risk factors, including metabolic dysfunction, alcohol intake, and other etiologies. flowchart: # Nodes : • Steatotic Liver Disease (SLD) (main category, leftmost node with icon) • MASLD (Metabolic dysfunction–associated steatotic liver disease) (blue rectangle) – Steatosis with ≥1 cardiometabolic risk factors: • Prediabetes or diabetes • Overweight or obesity • Dyslipidemia (or on lipid-lowering therapy) • Hypertension (or on BP-lowering medication) • MetALD (MASLD with increased alcohol intake) (dark red rectangle) – MASLD in the setting of increased alcohol consumption (between 20 and 50 g/day in women and 30 and 60 g/day in men) • ALD (Alcohol-associated liver disease) (orange rectangle) – Steatosis in the setting of sustained increased alcohol consumption (>50 g/day in women and >60 g/day in men) • Other Causes of SLD (gray rectangle) – Known causes: drug-induced steatosis, monogenic SLD, and others – Cryptogenic: unknown – Steatosis without cardiometabolic risk factors or without excessive alcohol use (future MASLD?) # Connectors : • SLD branches rightward into four categories: MASLD, MetALD, ALD, and Other Causes of SLD. • Each category is connected with a rightward arrow from SLD. • MetALD and ALD are sequentially related by alcohol intake thresholds. # Layout : • Vertical stack of four colored rectangles (MASLD, MetALD, ALD, Other Causes of SLD) to the right of the main SLD node. • Arrows point from the main SLD node to each category. • Explanatory bullet points within each rectangle. # Analysis : • The flowchart clarifies the new classification of SLD, distinguishing between metabolic and alcohol-related causes. • MASLD is defined by the presence of metabolic risk factors, while MetALD and ALD are differentiated by levels of alcohol intake. • "Other Causes" captures less common or unknown etiologies. • The structure emphasizes the importance of both metabolic and alcohol-related factors in the diagnosis and categorization of steatotic liver disease.

Summary : This flowchart presents a revised classification of myocardial infarction (MI) based on the presence or absence of acute coronary occlusion and the underlying mechanisms, as adapted from de Lemos et al. It visually distinguishes between MI with acute coronary occlusion and MI due to oxygen supply/demand mismatch without acute coronary occlusion, further subdividing each category by specific pathophysiological causes.

flowchart:
# Main Categories :
  • Acute myocardial injury with signs and/or symptoms of ischaemia (top-level node).
  • Two primary branches:
    – MI with acute coronary occlusion.
    – MI due to oxygen supply/demand mismatch without acute coronary occlusion.

# MI with Acute Coronary Occlusion (Left Branch) :
  • Plaque rupture/erosion with thrombus (circular illustration showing narrowed artery with thrombus).
  • Spontaneous coronary artery dissection (circular illustration showing dissection in artery wall).
  • Coronary embolism (circular illustration showing embolic obstruction).
  • Vasospasm or microvascular dysfunction (circular illustration showing narrowed vessel due to spasm).

# MI Due to Oxygen Supply/Demand Mismatch Without Acute Coronary Occlusion (Right Branch) :
  • With fixed obstructive CAD (circular illustration showing narrowed artery with stable plaque).
  • Without fixed obstructive CAD (circular illustration showing normal or non-obstructed artery).

# Connectors :
  • Downward arrows from the top node to the two main branches.
  • Further downward arrows from each main branch to their respective subcategories.

# Layout :
  • Hierarchical, top-down structure.
  • Two main branches split horizontally, each with multiple subcategories depicted with icons/illustrations.

# Technical Details :
  • Figure legend notes that both MI types may present with ECG changes of ST-segment elevation (STEMI) or non-ST-segment elevation (NSTEMI).
  • Abbreviations: CAD = coronary artery disease; MI = myocardial infarction.

Analysis :
  • The flowchart clarifies that MI can result from either acute coronary occlusion (with several distinct mechanisms) or from an imbalance in oxygen supply and demand without acute occlusion, with or without underlying coronary artery disease.
  • Visual icons help differentiate the pathophysiological processes, emphasizing the heterogeneity of MI causes.
  • The structure supports clinical differentiation for diagnosis and management.

Summary : This flowchart presents a revised classification of myocardial infarction (MI) based on the presence or absence of acute coronary occlusion and the underlying mechanisms, as adapted from de Lemos et al. It visually distinguishes between MI with acute coronary occlusion and MI due to oxygen supply/demand mismatch without acute coronary occlusion, further subdividing each category by specific pathophysiological causes. flowchart: # Main Categories : • Acute myocardial injury with signs and/or symptoms of ischaemia (top-level node). • Two primary branches: – MI with acute coronary occlusion. – MI due to oxygen supply/demand mismatch without acute coronary occlusion. # MI with Acute Coronary Occlusion (Left Branch) : • Plaque rupture/erosion with thrombus (circular illustration showing narrowed artery with thrombus). • Spontaneous coronary artery dissection (circular illustration showing dissection in artery wall). • Coronary embolism (circular illustration showing embolic obstruction). • Vasospasm or microvascular dysfunction (circular illustration showing narrowed vessel due to spasm). # MI Due to Oxygen Supply/Demand Mismatch Without Acute Coronary Occlusion (Right Branch) : • With fixed obstructive CAD (circular illustration showing narrowed artery with stable plaque). • Without fixed obstructive CAD (circular illustration showing normal or non-obstructed artery). # Connectors : • Downward arrows from the top node to the two main branches. • Further downward arrows from each main branch to their respective subcategories. # Layout : • Hierarchical, top-down structure. • Two main branches split horizontally, each with multiple subcategories depicted with icons/illustrations. # Technical Details : • Figure legend notes that both MI types may present with ECG changes of ST-segment elevation (STEMI) or non-ST-segment elevation (NSTEMI). • Abbreviations: CAD = coronary artery disease; MI = myocardial infarction. Analysis : • The flowchart clarifies that MI can result from either acute coronary occlusion (with several distinct mechanisms) or from an imbalance in oxygen supply and demand without acute occlusion, with or without underlying coronary artery disease. • Visual icons help differentiate the pathophysiological processes, emphasizing the heterogeneity of MI causes. • The structure supports clinical differentiation for diagnosis and management.

I now have comprehensive information from multiple authoritative sources. Let me compile a thorough, well-organized response.

Menstrual Abnormalities

A normal menstrual cycle occurs every 24-38 days, with flow lasting 4-8 days. Any deviation from this pattern - in timing, volume, regularity, or associated symptoms - constitutes a menstrual abnormality.

1. Classification & Terminology

TermDefinition
AmenorrheaAbsence of menstrual periods
OligomenorrheaReduced frequency of periods (cycles >38 days)
HypomenorrheaScanty flow during regular periods
Menorrhagia (HMB)Abnormally heavy/prolonged flow during regular periods
MetrorrhagiaBleeding from the uterus between periods (intermenstrual)
MenometrorrhagiaHeavy, irregular bleeding
DysmenorrheaPainful menstruation
PMS / PMDDPremenstrual syndrome / premenstrual dysphoric disorder
Note: Older terms like menorrhagia, metrorrhagia, and "dysfunctional uterine bleeding" have been largely replaced by the PALM-COEIN classification system (FIGO, 2011) for abnormal uterine bleeding (AUB).

2. Abnormal Uterine Bleeding (AUB) - PALM-COEIN

The PALM-COEIN system categorizes AUB causes into structural and non-structural:
PALM (Structural - diagnosed by imaging/histology):
  • P - Polyps
  • A - Adenomyosis
  • L - Leiomyoma (fibroids)
  • M - Malignancy and hyperplasia
COEIN (Non-structural / Medical):
  • C - Coagulopathy
  • O - Ovulatory dysfunction
  • E - Endometrial causes
  • I - Iatrogenic (medications)
  • N - Not otherwise classified
AUB causes by age group (Robbins):
  • Prepuberty: Precocious puberty (hypothalamic, pituitary, or ovarian origin)
  • Adolescence: Anovulatory cycles, coagulation disorders
  • Reproductive age: Pregnancy complications, structural lesions (polyps, fibroids), anovulation, coagulopathy
  • Perimenopausal: Anovulatory cycles (due to HPO axis fluctuations)
  • Postmenopausal: Atrophy (most common), endometrial malignancy

3. Amenorrhea

Primary vs. Secondary

  • Primary amenorrhea: Menstrual bleeding has never occurred. May be associated with absent secondary sexual characteristics.
  • Secondary amenorrhea: Cessation of previously normal menstrual cycles. The most common cause is pregnancy ("secondary amenorrhea should be considered due to pregnancy until proved otherwise").

Causes of Amenorrhea (Berek & Novak's Gynecology):

Without secondary sexual characteristics (Primary Amenorrhea):
  • Hypergonadotropic hypogonadism (e.g., Turner syndrome - 45,X)
  • Hypogonadotropic hypogonadism
    • Kallmann syndrome (GnRH deficiency + anosmia)
    • GnRH/FSH/LH receptor defects
    • Aromatase deficiency
With secondary sexual characteristics + pelvic anatomic abnormalities:
  • Outflow tract / Müllerian anomalies (e.g., imperforate hymen, Mayer-Rokitansky-Küster-Hauser syndrome)
  • Androgen insensitivity syndrome
  • Ovotesticular disorder of sexual development
With secondary sexual characteristics + normal pelvic anatomy:
  • Polycystic Ovarian Syndrome (PCOS) - most common endocrine cause
  • Hyperprolactinemia (pituitary adenoma, drug-induced)
  • Primary Ovarian Insufficiency (premature ovarian failure)
  • Hypothalamic amenorrhea - excess opioid activity slows GnRH pulse frequency; associated with:
    • Eating disorders / weight loss
    • Excessive exercise
    • Stress / emotional stimuli
    • Obesity
  • Thyroid disorders
  • Other hypothalamic/pituitary lesions
Key mechanism in hypothalamic amenorrhea: GnRH pulse frequency is slowed by excess opioid activity in the hypothalamus. Naltrexone (an opioid blocker) has shown encouraging results in restoring GnRH pulse frequency. - Ganong's Review of Medical Physiology

4. Dysfunctional Uterine Bleeding (DUB)

The most common cause of DUB is anovulation - failure to ovulate - which results in unopposed estrogen stimulation of the endometrium. Anovulatory cycles are most common:
  • At menarche (first 1-2 years)
  • In the perimenopausal period
Causes of anovulation include:
  • Pituitary tumors secreting prolactin (disrupts GnRH → ↓LH and FSH)
  • PCOS or functioning ovarian tumors (e.g., granulosa cell tumors)
  • Obesity, malnutrition, or chronic systemic disorders
  • Luteal phase defect (insufficient progesterone from corpus luteum)

5. Dysmenorrhea

Painful menstruation is classified as:
  • Primary dysmenorrhea: No identifiable pathology; due to excess prostaglandins (PGE2) in the uterus causing myometrial contractions and ischemia. Common in young women; often decreases after first pregnancy.
  • Secondary dysmenorrhea: Due to an underlying condition (endometriosis, fibroids, adenomyosis, pelvic inflammatory disease).

Treatment of Dysmenorrhea (Harrison's, 22nd Ed.):

  • NSAIDs (ibuprofen, naproxen, ketoprofen, mefenamic acid) - most effective (>80% response rate). Best started before onset of menses and continued 2-3 days.
  • Combined or progestin-only oral contraceptives (cyclic or continuous)
  • Vitamin B1 (100 mg/day), magnesium, omega-3 fatty acids - adjunct evidence
  • Heat application, exercise, yoga - modest benefit
  • Endometriosis-related: GnRH agonists with add-back therapy, aromatase inhibitors, laparoscopic resection

6. Premenstrual Syndrome (PMS) / PMDD

Symptoms (last 7-10 days of cycle, luteal phase):
  • Irritability, bloating, edema
  • Decreased concentration, depression
  • Headache, breast tenderness, constipation
Pathophysiology: Not fully understood. Salt/water retention and hormonal changes of the luteal phase are implicated, but symptom severity does not correlate with specific hormone levels.
Treatment:
  • SSRIs (e.g., fluoxetine) - first-line for PMDD (serotonin mechanism)
  • Benzodiazepines (alprazolam) - for anxiety/irritability
  • GnRH agonists (in doses that suppress the pituitary-ovarian axis) - effective for severe cases
  • Calcium, magnesium supplementation

7. Diagnostic Workup for AUB

Initial evaluation includes:
  1. Detailed history + pelvic exam
  2. Pregnancy test (first step)
  3. CBC, thyroid function, prolactin level
  4. Cervical cancer screening (Pap smear)
  5. STI screening
  6. Pelvic ultrasound
  7. Endometrial biopsy - indicated for:
    • Age ≥45 with AUB
    • <45 with risk factors (obesity, unopposed estrogen, persistent AUB, family history of endometrial cancer)
  8. Coagulation screening - if heavy bleeding since menarche, family history, medication-related
Postmenopausal bleeding - always abnormal; most common cause is endometrial atrophy, but malignancy must be excluded.

8. Treatment Summary

ConditionFirst-Line Treatment
Anovulatory AUBHormonal therapy (OCP, progestin, LNG-IUD)
Endometrial hyperplasiaProgestins, IUD; surgery if high-grade
FibroidsMedical (NSAIDs, tranexamic acid, GnRH agonists); surgical (myomectomy, UAE, ablation)
Primary dysmenorrheaNSAIDs, COCs
Hypothalamic amenorrheaAddress underlying cause; pulsatile GnRH, naltrexone
PMS/PMDDSSRIs (fluoxetine), alprazolam, GnRH agonists
PCOS-relatedOCP, metformin, lifestyle modification

Normal menstrual cycle diagram for reference:
Normal 28-day menstrual cycle showing gonadotropin levels, sex hormones, follicular development, and endometrial changes

Sources:
  • Ganong's Review of Medical Physiology, 26th Ed., Chapter 22 - Menstrual Abnormalities
  • Berek & Novak's Gynecology, Chapters 34 & 24 - Amenorrhea; PMS/PMDD
  • Harrison's Principles of Internal Medicine, 22nd Ed. - Dysmenorrhea, Endometriosis, Fibroids
  • Robbins & Kumar Basic Pathology - Abnormal Uterine Bleeding
  • Sabiston Textbook of Surgery - AUB/PALM-COEIN classification

Motor - Vehicle Act in Details

Asking for Preferences
Searching the Web

Motor Vehicles Act 1988 India complete details chapters provisions 2019 amendment

Searching the Web

Motor Vehicles Amendment Act 2019 India key changes penalties provisions

Reading Web Page

https://savelifefoundation.org/wp-content/uploads/2019/07/MV…

I now have comprehensive information. Here is the complete, detailed guide:

Motor Vehicles Act, 1988 (India) - Complete Guide

As amended by the Motor Vehicles (Amendment) Act, 2019 (No. 32 of 2019), in force from 1 September 2019

Overview

The Motor Vehicles Act, 1988 is the principal central legislation governing all aspects of road transport in India. It replaced the Motor Vehicles Act, 1939. The Act extends to the whole of India and has 14 Chapters and over 217 Sections. The Motor Vehicles (Amendment) Act, 2019 was a landmark overhaul focused on road safety, digital governance, and significantly enhanced penalties.

Structure - 14 Chapters at a Glance

ChapterTitleKey Sections
IPreliminary (Definitions)Sec. 2
IILicensing of DriversSec. 3-26
IIILicensing of ConductorsSec. 27-38
IVRegistration of Motor VehiclesSec. 39-65
VControl of Transport VehiclesSec. 66-96
VIState Transport UndertakingsSec. 97-104
VIIConstruction, Equipment & MaintenanceSec. 105-122
VIIIControl of TrafficSec. 123-138
IXMotor Vehicles Visiting IndiaSec. 139-140
XLiability Without FaultSec. 140-144
XIInsurance Against Third Party RisksSec. 145-164
XIIClaims TribunalsSec. 165-176
XIIIOffences, Penalties & ProcedureSec. 177-210
XIVMiscellaneousSec. 211-217

Chapter I - Preliminary (Definitions)

Section 2 defines key terms:
TermDefinition
Motor VehicleAny mechanically propelled vehicle adapted for use on roads, excluding vehicles running on fixed rails
Transport VehicleA public service vehicle, goods carriage, educational institution bus, or private service vehicle
Driving LicenseDocument issued by licensing authority authorizing to drive a motor vehicle
Light Motor Vehicle (LMV)Vehicle with gross vehicle weight not exceeding 7,500 kg
Heavy Motor Vehicle (HMV)Vehicle with gross vehicle weight exceeding 12,000 kg
Learner's LicenseLicense to drive a motor vehicle as a learner
RoadAny public road, bridge, lane, footway, square, court or passage

Chapter II - Licensing of Drivers (Sections 3-26)

Key Provisions

Section 3 - Necessity for Driving License
  • No person shall drive a motor vehicle in any public place unless they hold an effective driving license.
  • The license must specifically authorize the class of vehicle being driven.
Section 4 - Age Requirement
  • Minimum age: 18 years for most vehicles
  • Minimum age: 20 years for transport vehicles (carrying goods or passengers for hire)
Section 9 - Grant of Learner's License
  • An applicant must pass a test on traffic signs and driving rules.
  • A learner's license is valid for 6 months.
  • Must display an "L" plate while driving on a learner's license.
Section 10 - Form & Contents of Driving License
  • States name, address, date of birth, photograph, thumbprint, validity period, and vehicle class.
  • Under the 2019 Amendment: National Register of Driving Licenses established (Sec. 25A) - a centralized digital database.
Section 14 - Validity of Driving License
  • For transport vehicles: valid for 3 years (or until age 50, whichever is earlier)
  • For non-transport vehicles: valid for 20 years or until the holder turns 50, whichever is earlier; thereafter renewed every 5 years.
Section 19 - Power to Disqualify
  • Courts can disqualify a person from holding a driving license for repeat or serious offences.
2019 Amendment - New Provisions on Drivers:
  • Mandatory testing of HMV drivers for fitness and minimum educational qualifications
  • Training institutes for HMV drivers established under Section 12A
  • Provision for online issuance and renewal of driving licenses

Chapter III - Licensing of Conductors (Sections 27-38)

  • No person may act as a conductor of a stage carriage without a conductor's license.
  • Minimum age: 18 years
  • Must be medically fit and pass a conduct/knowledge test.
  • License valid for 3 years.

Chapter IV - Registration of Motor Vehicles (Sections 39-65)

Section 39 - No person shall drive an unregistered motor vehicle in any public place.
Section 41 - Registration by Registering Authority
  • Owner must apply to the registering authority (RTO) within 7 days of taking delivery.
  • Under 2019 Amendment: Vehicle dealers can now register new motor vehicles (previously prohibited).
  • National Register of Motor Vehicles (Sec. 62A) established - centralized digital records.
Section 43 - Temporary Registration
  • A motor vehicle dealer may obtain a temporary registration valid for 1 month.
Section 49 - Change of Residence
  • Owner must intimate the registering authority within 30 days if moving to another state.
Section 52 - Alteration of Motor Vehicle
  • No person shall alter a vehicle from its original specification without prior approval.
  • 2019 Amendment introduces heavy penalties for unauthorized alterations (Sec. 182A).
Section 56 - Certificate of Fitness
  • Every transport vehicle must carry a valid certificate of fitness.
  • Renewed periodically (every 1-2 years for commercial vehicles).

Chapter V - Control of Transport Vehicles (Sections 66-96)

Section 66 - Permit Required
  • No owner of a motor vehicle shall use it as a transport vehicle unless a permit has been granted.
Types of Permits:
PermitDescription
Stage Carriage PermitBus operations on specified routes
Contract Carriage PermitVehicles hired for specific trips (e.g., taxis, autos)
Goods Carriage PermitCarriage of goods for hire or reward
National PermitAllows goods vehicles to operate across states
Tourist PermitFor tourist vehicles operating across state borders
2019 Amendment - New Additions:
  • Section 66A - National Transportation Policy empowers Central Government to formulate a framework for integrated transport planning.
  • Section 66B - National Freight Policy for goods vehicles.

Chapter VII - Construction, Equipment & Maintenance (Sections 105-122)

  • Sets technical standards for vehicles: brakes, steering, lighting, horns, tyres, speed governors, etc.
  • 2019 Amendment - Vehicle Recall (Sections 110A & 110B):
    • Central Government empowered to recall vehicles that do not meet safety/emission standards.
    • Testing agencies established to issue certificates of approval.
    • Penalty for defective vehicles: up to Rs. 1 crore per model defect.

Chapter VIII - Control of Traffic (Sections 123-138)

Key Sections:
  • Sec. 112 - Speed limits (notified by state governments / Central Government on national highways)
  • Sec. 119 - Driving regulations (left-hand traffic, lane discipline, overtaking rules)
  • Sec. 129 - Wearing of protective headgear (helmet) - mandatory for two-wheeler riders
  • Sec. 134 - Duty of driver in case of accident - must stop, render assistance, report to police
  • Sec. 138 - Power to make rules for control of traffic
2019 Amendment - Good Samaritan Protection:
  • A "Good Samaritan" (bystander who assists accident victim in good faith) is protected from civil and criminal liability.
  • Cannot be compelled to be a witness.

Chapter X - Liability Without Fault (Sections 140-144)

  • Section 140 - Establishes no-fault liability: In case of death or permanent disablement caused by a motor accident, compensation is payable regardless of fault.
    • Compensation for death: Rs. 50,000
    • Compensation for permanent disablement: Rs. 25,000
  • These are minimum statutory amounts; full tort claims are adjudicated by Motor Accident Claims Tribunals (Chapter XII).

Chapter XI - Insurance Against Third Party Risks (Sections 145-164)

Section 146 - Compulsory Third Party Insurance
  • No person shall use a motor vehicle in a public place without a policy of insurance covering third party risks.
  • This is mandatory - driving without insurance is a punishable offence.
Section 147 - Requirements of policy:
  • Must cover death or bodily injury to any person (including passengers in certain vehicles).
  • Must cover damage to third-party property.
Section 163A - Special provisions for payment of compensation (structured formula-based payment for accidents without prolonged litigation).
2019 Amendment:
  • Motor Vehicle Accident Fund established to provide hit-and-run compensation.
  • Interim relief to be provided to road accident victims immediately.
  • Solatium Fund enhanced for hit-and-run cases.

Chapter XII - Claims Tribunals (Sections 165-176)

  • Motor Accident Claims Tribunals (MACTs) are established by State Governments to adjudicate compensation claims.
  • Section 166: Applications for compensation must be made within 6 months (extendable for sufficient cause).
  • Tribunal applies both fault-based and no-fault liability principles.
  • Appeals from MACT go to the High Court.

Chapter XIII - Offences, Penalties & Procedure

Complete Penalty Table (Pre vs. Post 2019 Amendment)

SectionOffenceOld Fine (₹)New Fine (₹)
177General traffic violation100 / 300500 / 1,500
177ARoad regulation violation100500-1,000
178Travelling without ticket200500
179Disobeying orders of authority5002,000
180Allowing unauthorized person to drive1,0005,000
181Driving without license5005,000
182(1)Driving despite disqualification50010,000
182BOversize vehiclesNIL5,000-10,000
183(1)Over-speeding (LMV)4001,000-2,000
184Dangerous/rash driving1,0001,000-5,000
185Drunken driving (1st offence)2,00010,000 + 6 months jail
185Drunken driving (2nd offence)3,00015,000 + 2 years jail
186Driving when mentally/physically unfit2001,000-2,000
192Using unregistered vehicle2,000-5,0002,000-5,000 (+ enhanced)
194Overloading2,000 + 1,000/extra tonne20,000 + 2,000/extra tonne
194ACarrying excess passengersNIL200 per excess passenger
194BNot using seat belt1001,000
194CNo helmet (two-wheeler)NIL1,000 + 3 months DL suspension
194DNot wearing helmetNIL1,000 + 3 months DL suspension
194ENot giving way to emergency vehiclesNIL10,000 + 6 months jail
194FUsing phone in silent zoneNILFine specified
196Driving without insurance1,0002,000 / 3 months jail
199AOffence by juvenile (guardian liable)NIL25,000 + 3 years jail + DL cancellation for 12 months; juvenile ineligible for DL till age 25
199BAnnual revision of finesNILUp to 10% annual increase
201Causing obstruction to traffic flow50/hour500
210AState govt. penalty multiplierNILStates can multiply fine by 1x to 10x
210BPenalty for corrupt enforcing officerNILTwice the applicable fine

Key New Provisions of the 2019 Amendment

1. National Road Safety Board (Sec. 215D)

  • First-ever national body for road safety.
  • Advises Central and State Governments on all matters relating to road safety and traffic management.

2. Vehicle Recall (Sec. 110A-110B)

  • Central Government can order recall of defective vehicles.
  • Manufacturers must refund or replace recalled vehicles.

3. Good Samaritan Protection

  • Legal protection to bystanders who assist road accident victims.
  • Helps overcome bystander apathy that costs lives.

4. National Transportation Policy (Sec. 66A)

  • Framework for integrated, multimodal transport planning.
  • States consulted before finalization.

5. National Registers

  • National Register of Driving Licenses - central digital database for all DLs.
  • National Register of Motor Vehicles - central digital database for all vehicle registrations.

6. Online Services

  • Driving licenses and vehicle registration now issuable online.
  • Faceless services to reduce corruption at RTOs.

7. Accident Compensation Fund

  • Motor Vehicle Accident Fund to provide immediate interim relief to accident victims.
  • Covers hit-and-run victims who previously received minimal compensation.

8. Juvenile Offences (Sec. 199A)

  • When a minor drives and causes an offence, the guardian/owner is deemed guilty.
  • Fine: ₹25,000 + imprisonment up to 3 years.
  • Vehicle registration cancelled for 12 months.
  • Juvenile made ineligible to obtain driving license until age 25.

9. Contractor Accountability (Sec. 198A)

  • Road contractors, consultants, and concessionaires are now penalized (up to ₹1,00,000) for faulty road design, engineering, or maintenance that causes accidents.

Important Legal Principles

PrincipleProvision
Compulsory InsuranceNo vehicle can ply on public roads without third party insurance (Sec. 146)
No-Fault LiabilityCompensation payable for death/disability regardless of who was at fault (Sec. 140)
Hit-and-Run CompensationCentral government fund provides compensation even when the offending vehicle is untraceable
Solatium FundFixed compensation for hit-and-run: ₹2 lakh for death, ₹50,000 for grievous injury (enhanced post-2019)
Duty to AssistDrivers involved in accidents must stop, render aid, and report to police (Sec. 134)

Administration & Enforcement

AuthorityRole
Central Government (MoRTH)Policy, national highways, national permits, standards
State Transport Authority (STA)State-level permits, licensing policy
Regional Transport Office (RTO)Licensing, registration, fitness certificates
Traffic PoliceEnforcement of traffic rules on roads
Motor Accident Claims Tribunal (MACT)Adjudication of accident compensation claims
National Road Safety BoardAdvisory body on road safety (new, 2019)

Key Cases & Judicial Interpretations

  • Shyam Narayan Chouksey v. Union of India (2018): Supreme Court mandated playing of national anthem in cinemas - upheld dignity norms extending to public behaviour.
  • Mukund Dewangan v. Oriental Insurance Co. (2017): SC clarified that a LMV license also covers transport vehicles of similar class.
  • Rajesh & Others v. Rajbir Singh (2013): SC held that income of non-earning housewives must be considered for compensation under MV Act.

Quick Reference - Common Violations

Most important rules for everyday compliance:
  1. Always carry: Driving License, RC Book, Insurance Certificate, PUC Certificate
  2. Wear helmet (two-wheelers) and seat belt (four-wheelers) - mandatory
  3. Do not use mobile phone while driving
  4. Do not drink and drive (Zero tolerance: BAC limit = 30 mg per 100 ml blood)
  5. Follow speed limits (residential: 30 km/h; city: 50 km/h; highways: 100-120 km/h)
  6. Give way to emergency vehicles (ambulance, fire brigade) - failure attracts ₹10,000 fine

This is a shared conversation. Sign in to Orris to start your own chat.